Device Trial Radar · NCT03603600
Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens
Last checked: Nov 19, 2026Latest source record: Dec 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
501
Actual
Start
May 31, 2018
Primary completion
May 4, 2023
Study completion May 4, 2023
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 27, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of the study is to evaluate the safety and effectiveness of the enVista trifocal intraocular lens when implanted in the capsular bag.
Conditions
- Cataract
Interventions
enVista MX60EDevice
enVista MX60E monofocal IOL
enVista MX60EFDevice
enVista MX60EF (trifocal) multifocal IOL (MIOL)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Photopic Monocular Best-corrected Distance Visual Acuity (BCDVA)Time frame: Day 120 to Day 180 after second eye implantation, up to 210 days from first eye implantation at Baseline.
- Photopic Monocular Distance-corrected Near Visual Acuity (DCNVA)Time frame: Day 120 to Day 180 after second eye implantation, up to 210 days from first eye implantation at Baseline.
- Photopic Monocular Distance-corrected Intermediate Visual Acuity (DCIVA)Time frame: Day 120 to Day 180 after second eye implantation, up to 210 days from first eye implantation at Baseline.
3 more outcomes with a free account
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Bausch Site 108
Fayetteville, Arkansas
Bausch Site 113
Garden Grove, California
Bausch Site 120
Northridge, California
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.